| Financial Year |
March 31 2023 |
| Monetary Funds |
462,349,537.17 |
| Held-for-trading Financial Assets |
20,055,241.09 |
| Notes Receivable |
-- |
| Accounts Receivable |
628,132,105.17 |
| Advances to Suppliers |
62,864,541.07 |
| Other Receivables |
15,400,659.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,137,271,111.28 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
105,215,814.50 |
| Total Current Assets |
2,431,289,009.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
889,081.11 |
| Fixed Assetes |
1,487,399,741.45 |
| Under-construction Projects |
63,890,946.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
119,970,209.88 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
245,226,771.43 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
171,579,079.37 |
| Deferred Income Tax Assets |
1,802,097.90 |
| Other Non-Current Assets |
41,126,785.97 |
| Sub-Total of Non-Current Assets |
2,606,001,949.97 |
| Total Assets |
5,037,290,959.96 |
| Short-Term Loans |
1,006,873,856.70 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
654,507,157.41 |
| Accounts Received In Advance |
47,250.00 |
| Employee Compensation Payable |
117,982,961.51 |
| Taxes Payable |
9,405,841.38 |
| Interest Payable |
-- |
| Dividend Payable |
250,000.00 |
| Other payables |
100,111,463.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
126,125,293.67 |
| Other Current Liabilities |
3,366,971.74 |
| Sub-Total of Current Liabilities |
2,060,527,848.19 |
| Long-term Loans |
285,878,223.82 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
236,711.53 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
819,937,372.80 |
| Total Liabilities |
2,880,465,220.99 |
| Paid-In Capital(Or Share Stock) |
448,979,593.00 |
| Capital Surplus |
710,116,922.05 |
| Surplus Reserve |
53,373,145.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
860,024,129.53 |
| Minority Stockholder's Interest |
84,331,948.82 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,072,493,790.15 |
| Owner's Equity（Stockholder's Equity） |
2,156,825,738.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,037,290,959.96 |
